Jaypirca Plus Venclexta With or Without Rituxan May Be Beneficial in r/r CLL
Patients with relapsed or refractory chronic lymphocytic leukemia (r/r CLL) saw benefits from treatment with fixed-duration Jaypirca (pirtobrutinib) plus Venclexta (venetoclax; PV) and Jaypirca plus Venclexta and Rituxan (rituximab; PVR), researchers …